Levofloxacin + Levofloxacin
ApprovedUNKNOWN 0 views this week 0 watching💤 Quiet
Interest: 36/100
36
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Urinary Tract Infection
Conditions
Urinary Tract Infection
Trial Timeline
Apr 15, 2017 → Mar 1, 2018
NCT ID
NCT03160807About Levofloxacin + Levofloxacin
Levofloxacin + Levofloxacin is a approved stage product being developed by Dr. Reddy's Laboratories for Urinary Tract Infection. The current trial status is unknown. This product is registered under clinical trial identifier NCT03160807. Target conditions include Urinary Tract Infection.
What happened to similar drugs?
20 of 20 similar drugs in Urinary Tract Infection were approved
Approved (20) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
20
Activity
4
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03160807 | Approved | UNKNOWN |
Competing Products
20 competing products in Urinary Tract Infection